Clinical effectiveness of Lactobacillus reuteri in the treatment of peri-implant diseases: a systematic review and meta-analysis.

Journal of biological regulators and homeostatic agents 2021 Mar-Apr

filter terms:

In the last decades, the presence of peri-implant diseases (PD) has increased. One of the therapies currently used is probiotics with Lactobacillus reuteri (LR). The aim of this article is to determinate, through a systematic review and meta-analysis, the clinical effectiveness of LR in the treatment of PD. We searched the literature until January 2021, in the biomedical databases: Pubmed, Embase, Scielo, Science Direct, Scopus, SIGLE, LILACS, Google Scholar and Cochrane Central Registry of Clinical Trials. The selection criteria of the studies were: randomized controlled clinical trials, without language and time restriction, reporting the clinical effects (depth to probing, plaque index and bleeding index) of the LR in the PD treatment. The risk of study bias was analyzed through the Cochrane tool for randomized studies using Review Manager software. The search strategy resulted in 6 articles of which four investigated peri-implantitis and three peri-implant mucositis. All studies reported that there was a difference in the depth of the probing in the treatment of PD, in favor of the group using LR, though not always achieving significance. The use of LR can be clinically effective in terms of pocket depth reduction in the treatment of PD. Copyright 2020 Biolife Sas. www.biolifesas.org.

Citation

H I Arbildo-Vega, S Panda, A Bal, R Mohanty, A Rendón-Alvarado, A C Das, F H Cruzado-Oliva, E D Infantes-Ruíz, B Manfredi, H Vásquez-Rodrigo, C Mortellaro, M S Giacomello, M Parrini, A Greco Lucchina, M Del Fabbro. Clinical effectiveness of Lactobacillus reuteri in the treatment of peri-implant diseases: a systematic review and meta-analysis. Journal of biological regulators and homeostatic agents. 2021 Mar-Apr;35(2 Suppl. 1):79-88